SPONSOR
Beijing 302 Hospital
Total Trials
4
Recruiting
4
Phases
Phase 2
Conditions studied: HER2-negative Breast Cancer Brain MetastasesImmunological Non-Responders in People With HIVAcute Myeloid LeukemiaAMLRelapsed Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
Beijing 302 Hospital is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including HER2-negative Breast Cancer Brain Metastases, Immunological Non-Responders in People With HIV, Acute Myeloid Leukemia, AML.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Beijing 302 Hospital
How many clinical trials has Beijing 302 Hospital sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Beijing 302 Hospital, of which 4 are actively recruiting participants. These trials cover conditions including HER2-negative Breast Cancer Brain Metastases, Immunological Non-Responders in People With HIV, Acute Myeloid Leukemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Beijing 302 Hospital research focus on?
Beijing 302 Hospital clinical trials span HER2-negative Breast Cancer Brain Metastases, Immunological Non-Responders in People With HIV, Acute Myeloid Leukemia, AML, Relapsed Acute Myeloid Leukemia, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Beijing 302 Hospital clinical trial?
To participate in a Beijing 302 Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Beijing 302 Hospital trials with current recruitment status updated daily.
Clinical Trials by Beijing 302 Hospital
NCT06418594 Phase 2
Recruiting
Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis
HER2-negative Breast Cancer Brain Metastases
NCT07637877 Phase 2
Recruiting
Targeted Therapies for Immunological Non-Responders in People With HIV: A Multicenter Clinical Study
Immunological Non-Responders in People With HIV
NCT07078591 Phase 2
Recruiting
Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML
Acute Myeloid Leukemia
NCT06741722 Phase 2
Recruiting
Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Based DCMG Regimen for R/R AML
AML
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology